Benralizumab for chronic obstructive pulmonary disease and sputum eosinophilia: a randomised, double-blind, placebo-controlled, phase 2a study (Q37371731)
Jump to navigation
Jump to search
scientific article published on 07 September 2014
Language | Label | Description | Also known as |
---|---|---|---|
English | Benralizumab for chronic obstructive pulmonary disease and sputum eosinophilia: a randomised, double-blind, placebo-controlled, phase 2a study |
scientific article published on 07 September 2014 |
Statements
1 reference
Benralizumab for chronic obstructive pulmonary disease and sputum eosinophilia: a randomised, double-blind, placebo-controlled, phase 2a study (English)
1 reference
Reynold A Panettieri
Dewei She
Christine K Ward
Xiao Xu
Claire Birrell
René van der Merwe
7 September 2014
1 reference